04/25/2024 3:26 PM | BioCryst Pharmaceuticals (Filer)
| Form ARS | |
04/02/2024 3:21 PM | BioCryst Pharmaceuticals (Issuer) Thackray Helen M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 3:32 PM | BioCryst Pharmaceuticals (Issuer) HEGGIE THERESA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 8:02 AM | Avoro Capital Advisors LLC (Filed by) BioCryst Pharmaceuticals (Subject)
| Form SC 13G | |
01/24/2024 4:23 PM | BioCryst Pharmaceuticals (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/24/2024 12:06 PM | BioCryst Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
|
01/18/2024 4:21 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 6:02 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2023 3:40 PM | BioCryst Pharmaceuticals (Issuer) Stonehouse Jon P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:42 PM | BioCryst Pharmaceuticals (Issuer) Thackray Helen M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:33 PM | Barnes Alane P (Reporting) BioCryst Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:35 PM | BioCryst Pharmaceuticals (Issuer) Doyle Anthony (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:38 PM | BioCryst Pharmaceuticals (Issuer) Gayer Charles K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:40 PM | BioCryst Pharmaceuticals (Issuer) Gayer Charles K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:43 PM | BioCryst Pharmaceuticals (Issuer) Stonehouse Jon P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:47 PM | BioCryst Pharmaceuticals (Issuer) Thackray Helen M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:34 PM | Barnes Alane P (Reporting) BioCryst Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:37 PM | BioCryst Pharmaceuticals (Issuer) Doyle Anthony (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 3:42 PM | BioCryst Pharmaceuticals (Issuer) MILANO VINCENT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 3:40 PM | BioCryst Pharmaceuticals (Issuer) HEGGIE THERESA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 6:37 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/30/2023 8:04 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 3:29 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/03/2023 11:14 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 11:16 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/26/2023 8:36 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2023 3:41 PM | BioCryst Pharmaceuticals (Issuer) HEGGIE THERESA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:43 PM | BioCryst Pharmaceuticals (Issuer) MILANO VINCENT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 6:04 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2023 6:00 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/30/2023 6:33 AM | BioCryst Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/15/2023 3:40 PM | BioCryst Pharmaceuticals (Issuer) Galson Steven K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:42 PM | BioCryst Pharmaceuticals (Issuer) LEE KENNETH B JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:43 PM | BioCryst Pharmaceuticals (Issuer) LEVIN ALAN G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:50 PM | BioCryst Pharmaceuticals (Issuer) Stonehouse Jon P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:31 PM | BioCryst Pharmaceuticals (Issuer) McKee Amy E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:33 PM | BioCryst Pharmaceuticals (Issuer) Hutson Nancy J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:35 PM | BioCryst Pharmaceuticals (Issuer) MILANO VINCENT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:37 PM | BioCryst Pharmaceuticals (Issuer) SANDERS MACHELLE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
06/15/2023 3:39 PM | ASELAGE STEVE (Reporting) BioCryst Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:28 PM | ABERCROMBIE GEORGE B (Reporting) BioCryst Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:29 PM | BioCryst Pharmaceuticals (Issuer) HEGGIE THERESA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 9:19 AM | BioCryst Pharmaceuticals (Subject) SANDERS MACHELLE (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023 10:32 AM | BioCryst Pharmaceuticals (Subject) Hutson Nancy J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023 6:02 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2023 3:32 PM | BioCryst Pharmaceuticals (Issuer) HEGGIE THERESA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 6:08 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |